Cellectis SA (CLLS)
3.21
-0.20
(-5.73%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
0.00 (0.00%)
After-Hours: 20:00
Cellectis Total Liabilities (Quarterly) : 226.30M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 226.30M |
| March 31, 2026 | 229.27M |
| December 31, 2025 | 255.58M |
| September 30, 2025 | 242.57M |
| June 30, 2025 | 256.86M |
| March 31, 2025 | 247.88M |
| December 31, 2024 | 261.52M |
| September 30, 2024 | 266.45M |
| June 30, 2024 | 258.54M |
| March 31, 2024 | 263.89M |
| December 31, 2023 | 249.58M |
| September 30, 2023 | 133.58M |
| June 30, 2023 | 131.12M |
| March 31, 2023 | 130.92M |
| December 31, 2022 | 135.28M |
| September 30, 2022 | 133.97M |
| June 30, 2022 | 140.36M |
| March 31, 2022 | 144.14M |
| December 31, 2021 | 145.60M |
| September 30, 2021 | 150.74M |
| June 30, 2021 | 155.24M |
| March 31, 2021 | 152.97M |
| December 31, 2020 | 160.62M |
| Date | Value |
|---|---|
| September 30, 2020 | 158.75M |
| June 30, 2020 | 127.64M |
| March 31, 2020 | 100.55M |
| December 31, 2019 | 112.00M |
| September 30, 2019 | 98.70M |
| June 30, 2019 | 100.22M |
| March 31, 2019 | 79.63M |
| December 31, 2018 | 50.57M |
| September 30, 2018 | 48.48M |
| June 30, 2018 | 45.29M |
| March 31, 2018 | 47.31M |
| December 31, 2017 | 46.98M |
| September 30, 2017 | 49.41M |
| June 30, 2017 | 57.03M |
| March 31, 2017 | 54.54M |
| December 31, 2016 | 56.80M |
| September 30, 2016 | 66.43M |
| June 30, 2016 | 73.73M |
| March 31, 2016 | 78.30M |
| December 31, 2015 | 84.13M |
| September 30, 2015 | 69.83M |
| June 30, 2015 | 71.38M |
| March 31, 2015 | 84.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 62.80M |
| Akari Therapeutics Plc | 20.03M |
| EDAP TMS SA | 77.77M |
| Autolus Therapeutics Plc | 418.39M |
| Evaxion AS | 9.849M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 267.36M |
| Shareholders Equity (Quarterly) | 41.07M |
| Debt to Equity Ratio | 2.539 |
| Current Ratio | 1.366 |
| Net Debt Paydown Yield | 0.30% |